Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Conditions
Early-stage Breast Cancer · Hormone Receptor Positive Breast Carcinoma · Invasive Breast Cancer · Stage II Breast Cancer · Stage IIA Breast Cancer · Stage IIB Breast Cancer · Stage III Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
St. Joseph Heritage Healthcare, Fullerton, California, United States
Contact: Principal Investigator (William E. Lawler, M.D.)Cancer Blood and Specialty Clinic, Los Alamitos, California, United States
Contact: Principal Investigator (Vu Phan, M.D.)UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Nicholas P McAndrew, M.D.)Torrance Memorial Physician Network / Cancer Care, Torrance, California, United States
Contact: Principal Investigator (David Chan, M.D.)PIH Health, Whittier, California, United States
Contact: Principal Investigator (Lisa Shing-E Lu Wang, M.D.)Orlando Health, Inc. d/b/a Orlando Health UF Health Center, Orlando, Florida, United States
Ft. Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
Cancer Center of Kansas, Wichita, Kansas, United States
Contact: Principal Investigator (Shaker Dakhil, M.D.)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Laura M Spring, M.D.)
Study leads
Nicholas P McAndrew, MD
Principal Investigator
UCLA / Jonsson Comprehensive Cancer Center